PRISMMARKETVIEW Tracker

[OS Therapies NYSE American: OSTX @OSTherapies]

$OSTX
We are very encouraged by our breast cancer data! We’ve reported positive safety data from the Phase 1 trial of OST-HER2 in HER2-expressing breast cancer, showing over 90% tumor reduction and prevention of brain metastases in preclinical models. https://t.co/lgxn7sSehR

[Quoin Pharmaceuticals @QuoinPharma]

Quoin $QNRX released its financial results for Q2 ended June 30, 2024, marking solid progress as we continue to advance and expand our clinical development with a mission to deliver treatments to the rare disease community.
#nethertonsyndrome #peelingskinsyndrome #clinicaltrials

[OS Therapies NYSE American: OSTX @OSTherapies]

$OSTX We are honored to be welcomed by the NYSE family. We extend our gratitude to our talented employees, advisors, and partners—your hard work and support have been instrumental. Here's to continued growth and collaboration. Together, we can transform cancer treatment.

[Quoin Pharmaceuticals @QuoinPharma]

We are pleased to announce the planned initiation of a clinical study to evaluate the safety and efficacy of QRX003 in a pediatric patient with Peeling Skin Syndrome (PSS). This marks a significant step in our strategy https://t.co/c4GwyOM76t
Quoin Pharmaceuticals $QNRX

[PRISMMARKETVIEW Tracker @PMV_Tracker]

We are pleased to announce the pricing of our $6.4 million initial public offering on the NYSE American exchange under symbol “ $OSTX ”. Read the release here: https://t.co/u1Y5Yk8SHq

[OS Therapies NYSE American: OSTX @OSTherapies]

.@OSTherapies $OSTX We are pleased to announce the pricing of our $6.4 million initial public offering on the NYSE American exchange under symbol “OSTX”. Read the release here: https://t.co/B804ZRcaQT

[PRISMMARKETVIEW Tracker @PMV_Tracker]

We are pleased to announce the pricing of our $6.4 million initial public offering on the NYSE American exchange under symbol “ $OSTX ”. Read the release here: https://t.co/u1Y5Yk8SHq

[Lipella @LipellaPharma]

Lipella has successfully enrolled the first patients into our Phase 2a trial for LP-310 in OLP. Top-line data is expected by YE- 2024.
#ClinicalTrials #PatientCare #OralLichenPlanus $LIPO
https://t.co/ZHU0ojOIxi

[BioStem Technologies @BSEM_Tech]

Great excuse to eat cake, as we celebrated the birthdays of Jonathan, Alex and Wendy this week! Happy Birthday...the best is yet to come! $BSEM

[Soligenix, Inc. @Soligenix_Inc]

Q&A with Dr. Ellen Kim, the Lead Principal Investigator for Soligenix’s Phase 3 FLASH study in CTCL:

Soligenix's Hybryte: Lighting the Way Towards Commercial Success with Promising Flash Study Results https://t.co/kqA9KLZt5T

#Hybryte #DefendYourHealth #biotech #clinicaltrials

[Soligenix, Inc. @Soligenix_Inc]

Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma
https://t.co/PIaAAuLFdU

#ctcl #positiveclinicalresults #defendyourhealth #biotech #clinicalstudy $sngx

[BioStem Technologies @BSEM_Tech]

WOUND CARE WEDNESDAY: We continue to shed our spotlight on the men and women who treat our Veterans and help them heal. Today we want to shed that light on the Malcom Randall VA Center in Gainesville, Florida. Keep up the amazing work! $BSEM #woundcare

[NVIDIA AI @NVIDIAAI]

✨ Businesses can harness the power of #generativeAI to create and deploy custom models with NVIDIA AI Foundry.

➡️ https://t.co/CCvwQTmDS4 Learn how the service can supercharge generative AI initiatives.

[BioStem Technologies @BSEM_Tech]

VENDAJE® is an allograft derived from processing placental tissue. It is used as a protective barrier in treating hard to close wounds, such as Diabetic Foot Ulcers (DFUs). $BSEM #DFU #diabeticfootulcer #woundcare
https://t.co/vbD3CXA2LQ

[PRISM MarketView @PrismMarketView]

Stocks making the biggest moves premarket: CrowdStrike $CRWD, Bank of America $BAC, Nvidia $NVDA, Verizon $VZ and more
https://t.co/tsmwUSsvhN
#stockstowatch #stocksinnews #investors #daytrader #PrismMaketView #PrismDigitalMedia #PrismMediaWire

[PRISM MarketView @PrismMarketView]

Tech Stocks Rebound Ahead of Earnings: Markets Wrap
https://t.co/kKKtloELO9
Boeing Co. ( $BA)
Ryanair Holdings Plc (https://t.co/7FQgo6cUXj)
Verizon Communications Inc. ( $VZ)
McDonald’s Corp.( $MCD)
Berkshire Hathaway Inc.( $BRK-B)
#stockstowatch #stocksinnews #investors #daytrader #PrismMaketView #PrismDigitalMedia #PrismMediaWire #marketwrap #techstocks

[PRISM MarketView @PrismMarketView]

Emerging PRISM Index Cannabis Companies Slated to Report Earnings
https://t.co/tgnxcwr7A3
Clever Leaves ( $CLVR)
Canopy Growth Corporation ( $CGC)
High Tide, Inc. ( $HITI)
Tilray Brands, Inc. ( $TLRY)
Green Thumb Industries ( $GTBIF)
Trulieve Cannabis Corp. ( $TCNNF)
AYR Wellness ( $AYRWF)
Village Farms International, Inc. ( $VFF)
Leafy, Inc. ( $LFLY)
#stockstowatch #stocksinnews #investors #daytrader #PrismMaketView #PrismDigitalMedia #PrismMediaWire #cannabisstocks

[BioStem Technologies @BSEM_Tech]

Navigating the Future of Biologics with Optimism and Awareness: The journey of biologics in healthcare is an unfolding story of profound potential and persistent challenges. Click link for complete article: https://t.co/4Pg2N3IMF7. $BSEM #biologics #woundcare

[iMDx Inc. @iMDxInc]

🏅 Celebrating the #TransplantGamesAmerica! 🏅

At @OncocyteCorp we're inspired by the incredible stories of transplant recipients, donors, and their families. Join us in honoring these heroes and raising awareness about the life-saving impact of transplants!

#OCX #OrganDonation